BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stumpf J, Siepmann T, Lindner T, Karger C, Schwöbel J, Anders L, Faulhaber-Walter R, Schewe J, Martin H, Schirutschke H, Barnett K, Hüther J, Müller P, Langer T, Pluntke T, Anding-Rost K, Meistring F, Stehr T, Pietzonka A, Escher K, Cerny S, Rothe H, Pistrosch F, Seidel H, Paliege A, Beige J, Bast I, Steglich A, Gembardt F, Kessel F, Kröger H, Arndt P, Sradnick J, Frank K, Klimova A, Mauer R, Grählert X, Anft M, Blazquez-Navarro A, Westhoff TH, Stervbo U, Tonn T, Babel N, Hugo C. Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine. Lancet Reg Health Eur 2021;:100178. [PMID: 34318288 DOI: 10.1016/j.lanepe.2021.100178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Haller MC, Kaiser RA, Langthaler S, Brandstetter C, Apfalter P, Kerschner H, Cejka D. Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients. Transpl Int 2022;35:10026. [DOI: 10.3389/ti.2021.10026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Hamaya T, Hatakeyama S, Yoneyama T, Tobisawa Y, Kodama H, Fujita T, Murakami R, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Saitoh H, Narumi S, Tomita H, Ohyama C. Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients. Sci Rep 2022;12:5876. [PMID: 35393481 DOI: 10.1038/s41598-022-09897-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Julius U, Schatz U, Tselmin S, Morawietz H. COVID-19 and Lipid Disorders. Horm Metab Res 2022. [PMID: 35835148 DOI: 10.1055/a-1860-2610] [Reference Citation Analysis]
4 Rodríguez-Cubillo B, Moreno de la Higuera MA, Pérez-Flores I, Calvo Romero N, Aiffil AS, Arribi Vilela A, Peix B, Huertas S, Juez A, Sanchez-Fructuoso AI. Clinical Effectiveness of SARS-CoV-2 Vaccination in Renal Transplant Recipients. Antibody Levels Impact in Pneumonia and Death. Transplantation 2022. [PMID: 35859270 DOI: 10.1097/TP.0000000000004261] [Reference Citation Analysis]
5 Tillmann FP, Figiel L, Ricken J, Still H, Korte C, Plassmann G, von Landenberg P. Evolution of SARS-CoV-2-Neutralizing Antibodies after Two Standard Dose Vaccinations, Risk Factors for Non-Response and Effect of a Third Dose Booster Vaccination in Non-Responders on Hemodialysis: A Prospective Multi-Centre Cohort Study. J Clin Med 2021;10:5113. [PMID: 34768631 DOI: 10.3390/jcm10215113] [Reference Citation Analysis]
6 Schuller M, Pfeifer V, Kirsch AH, Klötzer KA, Mooslechner AA, Rosenkranz AR, Stiegler P, Schemmer P, Sourij H, Eller P, Prietl B, Eller K. B Cell Composition Is Altered After Kidney Transplantation and Transitional B Cells Correlate With SARS-CoV-2 Vaccination Response. Front Med (Lausanne) 2022;9:818882. [PMID: 35187002 DOI: 10.3389/fmed.2022.818882] [Reference Citation Analysis]
7 Affeldt P, Koehler FC, Brensing KA, Adam V, Burian J, Butt L, Gies M, Grundmann F, Hinrichs S, Johannis W, Kalisch N, Meyer-Delpho M, Oehm S, Platen E, Schöler C, Heger E, Steger G, Stippel D, Ziegelhöfer A, Benzing T, Klein F, Kurschat C, Müller RU, Cristanziano VD. Immune Responses to SARS-CoV-2 Infection and Vaccination in Dialysis Patients and Kidney Transplant Recipients. Microorganisms 2021;10:4. [PMID: 35056453 DOI: 10.3390/microorganisms10010004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wünsch K, Anastasiou OE, Alt M, Brochhagen L, Cherneha M, Thümmler L, van Baal L, Madel RJ, Lindemann M, Taube C, Witzke O, Rohn H, Krawczyk A, Jansen S. COVID-19 in Elderly, Immunocompromised or Diabetic Patients—From Immune Monitoring to Clinical Management in the Hospital. Viruses 2022;14:746. [DOI: 10.3390/v14040746] [Reference Citation Analysis]
9 Gonzalez-Perez M, Montes-Casado M, Conde P, Cervera I, Baranda J, Berges-Buxeda MJ, Perez-Olmeda M, Sanchez-Tarjuelo R, Utrero-Rico A, Lozano-Ojalvo D, Torre D, Schwarz M, Guccione E, Camara C, Llópez-Carratalá MR, Gonzalez-Parra E, Portoles P, Ortiz A, Portoles J, Ochando J. Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination. Front Immunol 2022;13:845882. [PMID: 35401504 DOI: 10.3389/fimmu.2022.845882] [Reference Citation Analysis]
10 Jahn M, Korth J, Dorsch O, Anastasiou OE, Krawczyk A, Brochhagen L, van de Sand L, Sorge-hädicke B, Tyczynski B, Witzke O, Dittmer U, Dolff S, Wilde B, Kribben A. Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on Hemodialysis. Vaccines 2022;10:327. [DOI: 10.3390/vaccines10020327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Okumura K, Nishida S, Dhand A. Trends in COVID-19 Mortality Among Solid Organ Transplant Recipients: Implications for Prevention. Transplantation 2022. [PMID: 35442246 DOI: 10.1097/TP.0000000000004170] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yahav D, Rozen-Zvi B, Mashraki T, Atamna A, Ben-Zvi H, Bar-Haim E, Rahamimov R. Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study). BMJ Open 2021;11:e055611. [PMID: 34635537 DOI: 10.1136/bmjopen-2021-055611] [Reference Citation Analysis]
13 Fernández-Ruiz M, Almendro-Vázquez P, Carretero O, Ruiz-Merlo T, Laguna-Goya R, San Juan R, López-Medrano F, García-Ríos E, Más V, Moreno-Batenero M, Loinaz C, Andrés A, Pérez-Romero P, Paz-Artal E, Aguado JM. Discordance Between SARS-CoV-2-specific Cell-mediated and Antibody Responses Elicited by mRNA-1273 Vaccine in Kidney and Liver Transplant Recipients. Transplant Direct 2021;7:e794. [PMID: 34805496 DOI: 10.1097/TXD.0000000000001246] [Reference Citation Analysis]
14 Benning L, Morath C, Bartenschlager M, Nusshag C, Kälble F, Buylaert M, Schaier M, Beimler J, Klein K, Grenz J, Reichel P, Hidmark A, Ponath G, Töllner M, Reineke M, Rieger S, Tönshoff B, Schnitzler P, Zeier M, Süsal C, Bartenschlager R, Speer C. Neutralization of SARS-CoV-2 Variants of Concern in Kidney Transplant Recipients after Standard COVID-19 Vaccination. Clin J Am Soc Nephrol 2021:CJN. [PMID: 34937771 DOI: 10.2215/CJN.11820921] [Reference Citation Analysis]
15 Mehrabi Nejad MM, Shobeiri P, Dehghanbanadaki H, Tabary M, Aryannejad A, Haji Ghadery A, Shabani M, Moosaie F, SeyedAlinaghi S, Rezaei N. Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis. Virol J 2022;19:132. [PMID: 35941646 DOI: 10.1186/s12985-022-01858-3] [Reference Citation Analysis]
16 Mehrabi Nejad M, Moosaie F, Dehghanbanadaki H, Haji Ghadery A, Shabani M, Tabary M, Aryannejad A, Seyedalinaghi S, Rezaei N. Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis. Eur J Med Res 2022;27. [DOI: 10.1186/s40001-022-00648-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
17 Baron F, Canti L, Ariën KK, Kemlin D, Desombere I, Gerbaux M, Pannus P, Beguin Y, Marchant A, Humblet-baron S. Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients. Front Immunol 2022;13:827242. [DOI: 10.3389/fimmu.2022.827242] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kemlin D, Lemy A, Pannus P, Desombere I, Gemander N, Goossens ME, Marchant A, Le Moine A. Hybrid immunity to SARS-CoV-2 in kidney transplant recipients and hemodialysis patients. Am J Transplant 2021. [PMID: 34554629 DOI: 10.1111/ajt.16853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Mahalingasivam V, Su G, Iwagami M, Davids MR, Wetmore JB, Nitsch D. COVID-19 and kidney disease: insights from epidemiology to inform clinical practice. Nat Rev Nephrol 2022. [PMID: 35418695 DOI: 10.1038/s41581-022-00570-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Margioris AN. Immunosuppressed non-responders to two doses of mRNA SARS-CoV-2 vaccines achieve an immune response comparable to those of immunocompetent individuals after a third dose. Hormones (Athens) 2022. [PMID: 35750960 DOI: 10.1007/s42000-022-00365-y] [Reference Citation Analysis]
21 Prasithsirikul W, Nopsopon T, Phutrakool P, Suwanwattana P, Kantagowit P, Pongpirul W, Jongkaewwattana A, Pongpirul K. ChAdOx1 nCoV-19 Immunogenicity and Immunological Response Following COVID-19 Infection in Patients Receiving Maintenance Hemodialysis. Vaccines (Basel) 2022;10:959. [PMID: 35746567 DOI: 10.3390/vaccines10060959] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chammartin F, Kusejko K, Pasin C, Trkola A, Briel M, Amico P, Stoekle MP, Eichenberger AL, Hasse B, Braun DL, Schuurmans MM, Müller TF, Tamm M, Mueller NJ, Rauch A, Koller MT, Günthard HF, Bucher HC, Speich B, Abela IA; and the Swiss HIV Cohort Study. Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV. AIDS 2022;36:1465-8. [PMID: 35876706 DOI: 10.1097/QAD.0000000000003246] [Reference Citation Analysis]
23 Tharmaraj D, Dendle C, Polkinghorne KR, Mulley WR. Kidney transplant recipients' attitudes toward COVID-19 vaccination and barriers and enablers to vaccine acceptance. Transpl Infect Dis 2021;:e13749. [PMID: 34694682 DOI: 10.1111/tid.13749] [Reference Citation Analysis]
24 Carruthers JE, Wells J, Gupta A, Kallon D, Cox A, Pina N, Yaqoob MM, Rajakariar R. Response to Vaccination Against SARS-CoV-2 in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Renal Involvement. Front Med 2022;8:817845. [DOI: 10.3389/fmed.2021.817845] [Reference Citation Analysis]
25 Karakizlis H, Nahrgang C, Strecker K, Chen J, Aly M, Slanina H, Schüttler CG, Esso I, Wolter M, Todorova D, Jessen S, Adamik A, Ronco C, Seeger W, Weimer R, Sester M, Birk H, Husain-syed F. Immunogenicity and reactogenicity of homologous mRNA-based and vector-based SARS-CoV-2 vaccine regimens in patients receiving maintenance dialysis. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.108961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Galmiche S, Luong Nguyen LB, Tartour E, de Lamballerie X, Wittkop L, Loubet P, Launay O. Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review. Clin Microbiol Infect 2021:S1198-743X(21)00566-8. [PMID: 35020589 DOI: 10.1016/j.cmi.2021.09.036] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 24.0] [Reference Citation Analysis]
27 Melin J, Svensson MK, Albinsson B, Winqvist O, Pauksens K. Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients. BMC Immunol 2021;22:70. [PMID: 34666683 DOI: 10.1186/s12865-021-00458-0] [Reference Citation Analysis]
28 D'Offizi G, Agrati C, Visco-Comandini U, Castilletti C, Puro V, Piccolo P, Montalbano M, Meschi S, Tartaglia E, Sorace C, Leone S, Lapa D, Grassi G, Goletti D, Ippolito G, Vaia F, Ettorre GM, Lionetti R. Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients. Liver Int 2021. [PMID: 34719107 DOI: 10.1111/liv.15089] [Reference Citation Analysis]
29 Rzymski P, Poniedziałek B, Fal A. Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland. Vaccines (Basel) 2021;9:1286. [PMID: 34835217 DOI: 10.3390/vaccines9111286] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Nimmo A, Gardiner D, Ushiro-lumb I, Ravanan R, Forsythe JLR. The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic. Transplantation 2022;Publish Ahead of Print. [DOI: 10.1097/tp.0000000000004151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Duengelhoef P, Hartl J, Rüther D, Steinmann S, Brehm TT, Weltzsch JP, Glaser F, Schaub GM, Sterneck M, Sebode M, Weiler-Normann C, Addo MM, Lütgehetmann M, Haag F, Schramm C, Schulze Zur Wiesch J, Lohse AW. SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease. United European Gastroenterol J 2022. [PMID: 35289983 DOI: 10.1002/ueg2.12218] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
32 Zong K, Peng D, Yang H, Huang Z, Luo Y, Wang Y, Xiang S, Li T, Mou T, Wu Z. Risk Factors for Weak Antibody Response of SARS-CoV-2 Vaccine in Adult Solid Organ Transplant Recipients: A Systemic Review and Meta-Analysis. Front Immunol 2022;13:888385. [DOI: 10.3389/fimmu.2022.888385] [Reference Citation Analysis]
33 Mauro D, Ciancio A, Di Vico C, Passariello L, Rozza G, Pasquale MD, Pantano I, Cannistrà C, Bucci L, Scriffignano S, Riccio F, Patrone M, Scalise G, Ruscitti P, Montemurro MV, Giordano A, Vietri MT, Ciccia F. Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort. Front Immunol 2022;13:901055. [DOI: 10.3389/fimmu.2022.901055] [Reference Citation Analysis]
34 Stervbo U, Blazquez-Navarro A, Blanco EV, Safi L, Meister TL, Paniskaki K, Stockhausen M, Marheinecke C, Zimmer G, Wellenkötter J, Giglio T, Arora P, Pöhlmann S, Hoffmann M, Seibert FS, Pfaender S, Roch T, Westhoff TH, Cinkilic O, Babel N. Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease. Kidney Int 2021;100:1335-7. [PMID: 34619233 DOI: 10.1016/j.kint.2021.09.015] [Reference Citation Analysis]
35 Moreno NF, Mcadams R, Goss JA, Galvan NTN. COVID-19 Vaccine Efficacy and Immunogenicity in End-Stage Renal Disease Patients and Kidney Transplant Recipients. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00366-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Hirai K, Shimotashiro M, Sonoda T, Okumura T, Ookawara S, Morishita Y. Factors associated with anti-SARS-CoV-2 spike antibody titers after a second BNT162b2 mRNA COVID-19 vaccination in Japanese hemodialysis patients. Clin Exp Nephrol. [DOI: 10.1007/s10157-022-02223-y] [Reference Citation Analysis]
37 Chukwu CA, Mahmood K, Elmakki S, Gorton J, Kalra PA, Poulikakos D, Middleton R. Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre. PLoS One 2022;17:e0265130. [PMID: 35271655 DOI: 10.1371/journal.pone.0265130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
38 Piotrowska M, Zieliński M, Tylicki L, Biedunkiewicz B, Kubanek A, Ślizień Z, Polewska K, Tylicki P, Muchlado M, Sakowska J, Renke M, Sudoł A, Dąbrowska M, Lichodziejewska-niemierko M, Smiatacz T, Dębska-ślizień A, Trzonkowski P. Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine. Front Immunol 2022;13:832924. [DOI: 10.3389/fimmu.2022.832924] [Reference Citation Analysis]
39 Kumar D, Ferreira VH, Hall VG, Hu Q, Samson R, Ku T, Ierullo M, Majchrzak-Kita B, Tomlinson G, Gingras AC, Humar A. Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine : Secondary Analysis of a Randomized Trial. Ann Intern Med 2021. [PMID: 34807716 DOI: 10.7326/M21-3480] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 17.0] [Reference Citation Analysis]
40 Lindemann M, Klisanin V, Thümmler L, Fisenkci N, Tsachakis-Mück N, Ditschkowski M, Schwarzkopf S, Klump H, Reinhardt HC, Horn PA, Koldehoff M. Humoral and Cellular Vaccination Responses against SARS-CoV-2 in Hematopoietic Stem Cell Transplant Recipients. Vaccines (Basel) 2021;9:1075. [PMID: 34696183 DOI: 10.3390/vaccines9101075] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Ronicke S, Osmanodja B, Budde K, Jens A, Hammett C, Koch N, Zukunft B, Bachmann F, Choi M, Weber U, Eberspächer B, Hofmann J, Grunow F, Mikhailov M, Halleck F, Schrezenmeier E. Declining Course of Humoral Immune Response in Initially Responding Kidney Transplant Recipients after Repeated SARS-CoV-2 Vaccination. J Clin Med 2022;11:3291. [PMID: 35743365 DOI: 10.3390/jcm11123291] [Reference Citation Analysis]
42 Sattler A, Thumfart J, Tóth L, Schrezenmeier E, Proß V, Stahl C, Siegle J, He A, Thole LML, Ludwig C, Straub-hohenbleicher H, Friedersdorff F, Jahrsdörfer B, Schrezenmeier H, Bufler P, Kotsch K. SARS-CoV2 mRNA Vaccine-Specific B-, T- and Humoral Responses in Adolescents After Kidney Transplantation. Transpl Int 2022;35:10677. [DOI: 10.3389/ti.2022.10677] [Reference Citation Analysis]
43 Crespo M, Barrilado-Jackson A, Padilla E, Eguía J, Echeverria-Esnal D, Cao H, Faura A, Folgueiras M, Solà-Porta E, Pascual S, Barbosa F, Hurtado S, Ribera L, Río-No L, Pérez-Sáez MJ, Redondo-Pachón D, Pascual J; Mariscovid Research Group. Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring. Am J Transplant 2021. [PMID: 34551187 DOI: 10.1111/ajt.16854] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 11.0] [Reference Citation Analysis]
44 Tylicki L, Dębska-Ślizień A, Muchlado M, Ślizień Z, Gołębiewska J, Dąbrowska M, Biedunkiewicz B. Boosting Humoral Immunity from mRNA COVID-19 Vaccines in Kidney Transplant Recipients. Vaccines (Basel) 2021;10:56. [PMID: 35062717 DOI: 10.3390/vaccines10010056] [Reference Citation Analysis]
45 Speer C, Schaier M, Nusshag C, Töllner M, Buylaert M, Kälble F, Reichel P, Grenz J, Süsal C, Zeier M, Schnitzler P, Morath C, Klein K, Benning L. Longitudinal Humoral Responses after COVID-19 Vaccination in Peritoneal and Hemodialysis Patients over Twelve Weeks. Vaccines (Basel) 2021;9:1130. [PMID: 34696238 DOI: 10.3390/vaccines9101130] [Reference Citation Analysis]
46 Smith RM, Cooper DJ, Doffinger R, Stacey H, Al-mohammad A, Goodfellow I, Baker S, Lear S, Hosmilo M, Pritchard N, Torpey N, Jayne D, Yiu V, Chalisey A, Lee J, Vilnar E, Cheung CK, Jones RB. SARS-COV-2 vaccine responses in renal patient populations. BMC Nephrol 2022;23. [DOI: 10.1186/s12882-022-02792-w] [Reference Citation Analysis]
47 Roch T, Rohn B, Blazquez-navarro A, Meister TL, Blanco EV, Paniskaki K, Wellenkötter J, Zgoura P, Giglio T, Pfaender S, Stervbo U, Viebahn R, Cinkilic O, Westhoff TH, Babel N. A vector-based vaccine dose after three doses of mRNA-based COVID-19 vaccination does not substantially improve humoral SARS-CoV-2 immunity in renal transplant recipient. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.01.1068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Hasmann S, Paal M, Füeßl L, Fischereder M, Schönermarck U. Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients: (Response to: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.). Lancet Reg Health Eur 2021;10:100237. [PMID: 34723234 DOI: 10.1016/j.lanepe.2021.100237] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Cassaniti I, Bergami F, Arena F, Sammartino JC, Ferrari A, Zavaglio F, Curti I, Percivalle E, Meloni F, Pandolfi L, Pellegrini C, Turco A, Seminari E, Pattonieri EF, Gregorini M, Rampino T, Sarasini A, Lilleri D, Baldanti F. Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsiveness of SARS-CoV-2 Recovered Subjects against Delta Variant. Microorganisms 2021;9:2622. [PMID: 34946223 DOI: 10.3390/microorganisms9122622] [Reference Citation Analysis]
50 Bassi J, Giannini O, Silacci-Fregni C, Pertusini L, Hitz P, Terrot T, Franzosi Y, Muoio F, Saliba C, Meury M, Dellota EA Jr, Dillen JR, Hernandez P, Czudnochowski N, Cameroni E, Beria N, Ventresca M, Badellino A, Lavorato-Hadjeres S, Lecchi E, Bonora T, Mattiolo M, Trinci G, Garzoni D, Bonforte G, Forni-Ogna V, Giunzioni D, Berwert L, Gupta RK, Ferrari P, Ceschi A, Cippà P, Corti D, Lanzavecchia A, Piccoli L. Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients. PLoS One 2022;17:e0263328. [PMID: 35143540 DOI: 10.1371/journal.pone.0263328] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
51 Grupper A, Katchman H. SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00359-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
52 Malik SA, Modarage K, Goggolidou P. A systematic review assessing the effectiveness of COVID-19 mRNA vaccines in chronic kidney disease (CKD) individuals. F1000Res 2022;11:909. [DOI: 10.12688/f1000research.122820.1] [Reference Citation Analysis]
53 Tylicki P, Polewska K, Och A, Susmarska A, Puchalska-Reglińska E, Parczewska A, Biedunkiewicz B, Szabat K, Renke M, Tylicki L, Dębska-Ślizień A. Angiotensin Converting Enzyme Inhibitors May Increase While Active Vitamin D May Decrease the Risk of Severe Pneumonia in SARS-CoV-2 Infected Patients with Chronic Kidney Disease on Maintenance Hemodialysis. Viruses 2022;14:451. [PMID: 35336859 DOI: 10.3390/v14030451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Hall VG, Al-Alahmadi G, Solera JT, Marinelli T, Cardinal H, Prasad GVR, De Serres SA, Isaac D, Mainra R, Lamarche C, Sapir-Pichhadze R, Gilmour S, Matelski J, Humar A, Kumar D. Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study. Transplantation 2022. [PMID: 35502801 DOI: 10.1097/TP.0000000000004178] [Reference Citation Analysis]
55 El Karoui K, De Vriese AS. COVID-19 in dialysis: clinical impact, immune response, prevention and treatment. Kidney International 2022. [DOI: 10.1016/j.kint.2022.01.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
56 Mahallawi WH, Ibrahim NA, Mumena WA. Effectiveness of COVID-19 Vaccines in Patients Under Maintenance Hemodialysis. Risk Manag Healthc Policy 2021;14:5081-8. [PMID: 35002344 DOI: 10.2147/RMHP.S345686] [Reference Citation Analysis]
57 Lee ARYB, Wong SY, Chai LYA, Lee SC, Lee MX, Muthiah MD, Tay SH, Teo CB, Tan BKJ, Chan YH, Sundar R, Soon YY. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ 2022;376:e068632. [PMID: 35236664 DOI: 10.1136/bmj-2021-068632] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 28.0] [Reference Citation Analysis]
58 Osmanodja B, Ronicke S, Budde K, Jens A, Hammett C, Koch N, Seelow E, Waiser J, Zukunft B, Bachmann F, Choi M, Weber U, Eberspächer B, Hofmann J, Grunow F, Mikhailov M, Liefeldt L, Eckardt KU, Halleck F, Schrezenmeier E. Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients. J Clin Med 2022;11:2565. [PMID: 35566691 DOI: 10.3390/jcm11092565] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
59 Benning L, Klein K, Morath C, Bartenschlager M, Kim H, Buylaert M, Reineke M, Töllner M, Nusshag C, Kälble F, Reichel P, Schnitzler P, Zeier M, Süsal C, Bartenschlager R, Schaier M, Speer C. Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients. Front Immunol 2022;13:840136. [DOI: 10.3389/fimmu.2022.840136] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
60 Steenblock C, Schwarz PEH, Ludwig B, Linkermann A, Zimmet P, Kulebyakin K, Tkachuk VA, Markov AG, Lehnert H, de Angelis MH, Rietzsch H, Rodionov RN, Khunti K, Hopkins D, Birkenfeld AL, Boehm B, Holt RIG, Skyler JS, DeVries JH, Renard E, Eckel RH, Alberti KGMM, Geloneze B, Chan JC, Mbanya JC, Onyegbutulem HC, Ramachandran A, Basit A, Hassanein M, Bewick G, Spinas GA, Beuschlein F, Landgraf R, Rubino F, Mingrone G, Bornstein SR. COVID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol 2021;9:786-98. [PMID: 34619105 DOI: 10.1016/S2213-8587(21)00244-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 38.0] [Reference Citation Analysis]
61 Buchwinkler L, Solagna CA, Messner J, Pirklbauer M, Rudnicki M, Mayer G, Kerschbaum J. Antibody Response to mRNA Vaccines against SARS-CoV-2 with Chronic Kidney Disease, Hemodialysis, and after Kidney Transplantation. J Clin Med 2021;11:148. [PMID: 35011888 DOI: 10.3390/jcm11010148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Attias P, Azzaoui I, El Karoui K, de La Selle A, Sokal A, Chappert P, Grimbert P, Fernandez I, Bouvier M, Samson C, Dahmane D, Rieu P, Nizard P, Fourati S, Sakhi H, Mahévas M; Mondor NephroCov Study Group. Immune Responses after a Third Dose of mRNA Vaccine Differ in Virus-Naive versus SARS-CoV-2-Recovered Dialysis Patients. Clin J Am Soc Nephrol 2022:CJN. [PMID: 35764393 DOI: 10.2215/CJN.00830122] [Reference Citation Analysis]
63 Qin S, Tang X, Chen Y, Chen K, Fan N, Xiao W, Zheng Q, Li G, Teng Y, Wu M, Song X. mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduct Target Ther 2022;7:166. [PMID: 35597779 DOI: 10.1038/s41392-022-01007-w] [Reference Citation Analysis]
64 Verdier JF, Boyer S, Chalmin F, Jeribi A, Egasse C, Maggi MF, Auvray P, Yalaoui T. Response to three doses of the Pfizer/BioNTech BNT162b2 COVID-19 vaccine: a retrospective study of a cohort of haemodialysis patients in France. BMC Nephrol 2022;23:189. [PMID: 35585512 DOI: 10.1186/s12882-022-02751-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Dębska-Ślizień A, Ślizień Z, Muchlado M, Kubanek A, Piotrowska M, Dąbrowska M, Tarasewicz A, Chamienia A, Biedunkiewicz B, Renke M, Tylicki L. Predictors of Humoral Response to mRNA COVID19 Vaccines in Kidney Transplant Recipients: A Longitudinal Study-The COViNEPH Project. Vaccines (Basel) 2021;9:1165. [PMID: 34696273 DOI: 10.3390/vaccines9101165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
66 Lederer K, Parvathaneni K, Painter MM, Bettini E, Agarwal D, Lundgreen KA, Weirick M, Goel RR, Xu X, Drapeau EM, Gouma S, Greenplate AR, Coz CL, Romberg N, Jones L, Rosen M, Besharatian B, Kaminiski M, Weiskopf D, Sette A, Hensley SE, Bates P, Wherry EJ, Naji A, Bhoj V, Locci M. Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals. medRxiv 2021:2021. [PMID: 34580676 DOI: 10.1101/2021.09.16.21263686] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
67 Boongird S, Chuengsaman P, Setthaudom C, Nongnuch A, Assanatham M, Phanprasert S, Kitpermkiat R, Kiertiburanakul S, Malathum K, Phuphuakrat A, Davenport A, Bruminhent J. Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine. Infect Dis Ther 2021. [PMID: 34859359 DOI: 10.1007/s40121-021-00574-9] [Reference Citation Analysis]
68 Boedecker-Lips SC, Lautem A, Runkel S, Klimpke P, Kraus D, Keil P, Holtz S, Tomalla V, Marczynski P, Boedecker CB, Galle PR, Koch M, Weinmann-Menke J. Six-Month Follow-Up after Vaccination with BNT162b2: SARS-CoV-2 Antigen-Specific Cellular and Humoral Immune Responses in Hemodialysis Patients and Kidney Transplant Recipients. Pathogens 2022;11:67. [PMID: 35056015 DOI: 10.3390/pathogens11010067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
69 Marlet J, Gatault P, Maakaroun Z, Longuet H, Stefic K, Handala L, Eymieux S, Gyan E, Dartigeas C, Gaudy-Graffin C. Antibody Responses after a Third Dose of COVID-19 Vaccine in Kidney Transplant Recipients and Patients Treated for Chronic Lymphocytic Leukemia. Vaccines (Basel) 2021;9:1055. [PMID: 34696163 DOI: 10.3390/vaccines9101055] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
70 Chinnadurai R, Wu HHL, Cox E, Moore J, Clough T, Lamerton E, Donne R, O’riordan E, Poulikakos D. Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance. Vaccines 2022;10:498. [DOI: 10.3390/vaccines10040498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
71 Li H, Yu J, Cao B. SARS-CoV-2 vaccination for immune-comprised patients: More is required. Lancet Reg Health Eur 2021;9:100191. [PMID: 34423326 DOI: 10.1016/j.lanepe.2021.100191] [Reference Citation Analysis]
72 Bernea L, Ailioaie OR, Benhamouda N, Tartour E, Germain DP. Humoral Immune Response to SARS-CoV-2 Vaccination after a Booster Vaccine Dose in Two Kidney Transplant Recipients with Fabry Disease and Variable Secondary Immunosuppressive Regimens. Vaccines (Basel) 2021;9:1412. [PMID: 34960158 DOI: 10.3390/vaccines9121412] [Reference Citation Analysis]
73 Matsunami M, Suzuki T, Terao T, Kuji H, Matsue K. Immune response to SARS-CoV-2 vaccination among renal replacement therapy patients with CKD: a single-center study. Clin Exp Nephrol 2021. [PMID: 34746991 DOI: 10.1007/s10157-021-02156-y] [Reference Citation Analysis]